Session

Overview: This symposium explores the role of quantitative MRI biomarkers in radiation therapy (RT) response assessment, with a focus on their validation for multicenter clinical trials. Experts will discuss the integration of biological image-guided adaptive RT, standardization of MRI sequences, and robust parameter extraction across institutions. The session will also highlight the potential of deep learning in MRI parameter estimation and the role of hypoxia imaging in clinical trials. A panel discussion will address challenges and opportunities in advancing MRI biomarkers for precision RT.